| Mr Jose Ramon Couto-sepulveda, MD | |
|
863 Campeche St, Ponce, PR 00717 | |
| (787) 840-2125 | |
| (787) 840-2435 |
| Full Name | Mr Jose Ramon Couto-sepulveda |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 49 Years |
| Location | 863 Campeche St, Ponce, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356328736 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 6038 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jose Ramon Couto-sepulveda, MD Po Box 7294, 863 Campeche St, Ponce, PR 00732-7294 Ph: (787) 840-2125 | Mr Jose Ramon Couto-sepulveda, MD 863 Campeche St, Ponce, PR 00717 Ph: (787) 840-2125 |
News Archive
A new toxic entity associated with genetically inherited forms of dementia and motor neuron disease has been identified by scientists at the UCL Institute of Neurology. The toxin is the result of a genetic mutation that leads to the production of RNA molecules which could be responsible for the diseases. The findings are published in the journal Acta Neuropathologica.
Following today's (Friday 3 August) announcement of Merck and InnoCore's collaboration, Rahael Maladwala, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on what this might mean for biologic drug delivery:
In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB® (lapatinib) plus HERCEPTIN® (trastuzumab). The results of the Phase III study in HER2-positive metastatic breast cancer were presented during the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held in San Antonio, Texas (Dec. 9 - 13).
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2012 revenue of $27.4 million, up 25% compared to revenue of $22.0 million in the same period of fiscal 2011.
Most physicians paint overly optimistic prognoses for their patients, and many have withheld information concerning their medical mistakes and financial relationships with drug companies and device manufacturers, according to a national survey published in Health Affairs.
› Verified 1 days ago
Juan Pablo Torres, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 917 Ave Tito Castro, Ponce, PR 00716 Phone: 787-840-4545 | |
Dr. George Paul Fahed, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 917 Ave Tito Castro, Torre Medica San Lucas Suite 701, Ponce, PR 00716 Phone: 787-290-5577 Fax: 787-848-6644 | |
Dr. Carlos A Gaona Reyes, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1214 Ave Munoz Rivera, Recinto Universitario, Ponce, PR 00717 Phone: 787-284-0383 Fax: 787-987-9310 | |
Rafael Jose Rivera, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 909 Ave Tito Castro, Torre Medica San Lucassuite 504, Ponce, PR 00716 Phone: 787-651-1432 | |
Aurelio Garcia Medina, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Mansion Del Lago Calle 3 # 89, Ponce, PR 00732 Phone: 787-247-2427 | |
Marian Couto, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2225 Ponce By Pass, Edif Parra Ste 603, Ponce, PR 00717 Phone: 787-492-2000 Fax: 787-813-0517 | |
Mr. Gabriel Martinez-rodriguez, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: San Cristobal Anexo Torre I, Ponce, PR 00780 Phone: 787-848-2100 Fax: 787-813-1836 |